Toronto, Ontario, Canada-based Ventripoint Diagnostics has received CE Mark certification for its VMS+4.0 automated cardiac ultrasound software.
The certification will allow Ventripoint to engage in the next steps of country-specific introduction of VMS+4.0 in the European Union. VMS+4.0 offers automation of the image processing steps, which the company said can lead to a reduction in operator time without compromising the accuracy of the measurements.
VMS+V4.0 will be marketed as a premium product in Europe to complement the company's base product V3.2. VMS+ 4.0 already has a Medical Device License in Canada and is under review by the U.S. Food and Drug Administration.
